Tumor necrosis factor family members and inflammatory bowel disease

被引:61
|
作者
Wang, J [1 ]
Fu, YX [1 ]
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
关键词
D O I
10.1111/j.0105-2896.2005.00218.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor necrosis factor (TNF) is one of the most potent effector cytokines in the pathogenesis of inflammatory bowel disease (IBD). Previous studies strongly implicate the critical involvement of several TNF family members in human IBD. This review focuses on the recent studies of TNF family members in IBD development. In particular, we discuss the findings about LIGHT (homologous to lymphotoxins, inducible expression, competes with herpes simplex virus glycoprotein D for herpes viral entry mediator, a receptor expressed on T lymphocytes) in the pathogenesis of IBD, and the potential mechanisms by which LIGHT induces IBD. Such mechanisms may also apply to other TNF family members.
引用
收藏
页码:144 / 155
页数:12
相关论文
共 50 条
  • [41] Drug Insight: antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease
    John T Chang
    Gary R Lichtenstein
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 220 - 228
  • [42] Association of tumor necrosis factor-alpha and -beta gene polymorphisms in inflammatory bowel disease
    Al-Meghaiseeb, Ebtissam Saleh
    Al-Robayan, Abdulrahman A.
    Al-Otaibi, Mulfi Mubarak
    Arfin, Misbahul
    Al-Asmari, Abdulrahman K.
    JOURNAL OF INFLAMMATION RESEARCH, 2016, 9 : 133 - 140
  • [43] Beyond Tumor Necrosis Factor: Next-Generation Biologic Therapy for Inflammatory Bowel Disease
    Podolsky, Daniel K.
    DIGESTIVE DISEASES, 2009, 27 (03) : 366 - 369
  • [44] Tumor Necrosis Factor-alpha Gene Polymorphisms in Korean Children with Inflammatory Bowel Disease
    Cho, Min Sung
    Song, Seung Min
    Oh, Seak Hee
    Lee, Yeoun Joo
    Jang, Ju Young
    Kim, Kyung Mo
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2011, 14 (03) : 269 - 278
  • [45] Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
    Riestra, Sabin
    de Francisco, Ruth
    Arias-Guillen, Miguel
    Saro, Cristina
    Garcia-Alvarado, Maria
    Duque, Jose M.
    Jose Palacios, Juan
    Munoz, Fernando
    Blanco, Lorena
    Castano, Olegario
    Perez-Martinez, Isabel
    Martinez-Camblor, Pablo
    Perez-Hernandez, Dolores
    Suarez, Adolfo
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (09) : 541 - 549
  • [46] Biological therapy and histological tumor necrosis factor - alpha expression in Inflammatory Bowel Disease patients
    Bertani, A.
    Pecchini, M.
    Lami, F.
    Bonetti, L. Reggiani
    Caramaschi, S.
    Colecchia, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1995 - i1995
  • [47] Anxiety and Depression Leads to Anti-Tumor Necrosis Factor Discontinuation in Inflammatory Bowel Disease
    Dolovich, Casandra
    Bernstein, Charles N.
    Singh, Harminder
    Nugent, Zoann
    Tennakoon, Aruni
    Shafer, Leigh Ann
    Marrie, Ruth Ann
    Sareen, Jitender
    Targownik, Laura E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (06) : 1200 - +
  • [48] Tumor-Necrosis-Factor-α Antagonist Therapy for Inflammatory Bowel Disease After Liver Transplantation
    Parekh, R.
    Segovia, M.
    Kaur, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 666 - 667
  • [49] Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease
    Blandizzi, C.
    Tuccori, M.
    Ferraro, S.
    Leonardi, L.
    Convertino, I.
    DRUG SAFETY, 2019, 42 (10) : 1245 - 1245
  • [50] LOCATION OF TUMOR-NECROSIS-FACTOR-ALPHA BY IMMUNOHISTOCHEMISTRY IN CHRONIC INFLAMMATORY BOWEL-DISEASE
    MURCH, SH
    BRAEGGER, CP
    WALKERSMITH, JA
    MACDONALD, TT
    GUT, 1993, 34 (12) : 1705 - 1709